Janssen Pharmaceutica
Janssen Pharmaceutica
Janssen Pharmaceutica is a pharmaceutical company based in Belgium. It was founded in 1953 by Paul Janssen, a Belgian physician and pharmacologist. The company is a subsidiary of Johnson & Johnson, an American multinational corporation.
Pronunciation
Janssen Pharmaceutica: /ˈjænsən fɑːrməˈsiːtɪkə/
Etymology
The name "Janssen Pharmaceutica" is derived from its founder's name, Paul Janssen. The term "Pharmaceutica" is Latin for "pharmaceuticals", indicating the company's primary business.
Related Terms
History
Janssen Pharmaceutica was established in 1953 in Belgium by Dr. Paul Janssen. The company was initially a part of the family business, but it grew rapidly and was acquired by Johnson & Johnson in 1961. Since then, it has been a part of the Johnson & Johnson family of companies.
The company has been responsible for the discovery and development of more than 80 medicines, some of which are considered breakthroughs in their respective therapeutic areas. Janssen Pharmaceutica's research and development efforts are focused on a broad range of diseases, including mental health disorders, infectious diseases, oncology, and immunology.
See Also
External links
- Medical encyclopedia article on Janssen Pharmaceutica
- Wikipedia's article - Janssen Pharmaceutica
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski